Translesion synthesis past the Me-FAPy adduct in oligonucleotides by DNA polymerases

TOXI 118

Plamen P. Christov, plamen.p.christov@vanderbilt.edu1, Ivan D. Kozekov, ivan.kozekov@vanderbilt.edu2, Kyle L. Brown, kyle.l.brown@vanderbilt.edu1, Michael P. Stone, michael.p.stone@vanderbilt.edu2, Thomas M. Harris, thomas.m.harris@vanderbilt.edu1, and Carmelo J. Rizzo, c.j.rizzo@vanderbilt.edu2. (1) Department of Chemistry, Center in Molecular Toxicology and Vanderbilt Institute of Chemical Biology, Vanderbilt University, P.O. Box 1822, Nashville, TN 37235, (2) Department of Chemistry, Center in Molecular Toxicology and the Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN 37235

Methylating agents react with DNA to give a cationic N7-methyl deoxyguanosine adduct, which can undergo hydrolytic opening of the imidazole ring to form 2,6-diamino-4-hydroxy-N5-(methyl)-formamidopyrimidine (Me-FAPy) 1. We developed a four step synthesis of phosphoroamidite 2 in 24% overall yield, which allowed the preparation of oligodeoxynucleotides containing the Me-FAPy lesion. The in vitro replication of the Me-FAPy lesion was examined with eukaryotic and prokaryotic DNA polymerases and the full-length extension products were sequenced by tandem mass spectrometry. The Me-FAPy adduct was found to be mis-coding however, only the initial insertion of dCTP opposite the adduct could be extended.

 

 

Poster Session and Awards
6:00 PM-10:00 PM, Tuesday, August 21, 2007 BCEC -- 204 A/B, Poster

Sci-Mix
8:00 PM-10:00 PM, Monday, August 20, 2007 BCEC -- Exhibit Hall - B2, Sci-Mix

Division of Chemical Toxicology

The 234th ACS National Meeting, Boston, MA, August 19-23, 2007